BlackRock’s Nautilus Biotechnolgy NAUT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.03M Buy
2,687,226
+2,499,555
+1,332% +$6.6M ﹤0.01% 3923
2026
Q1
$728K Sell
187,671
-1,760
-0.9% -$4.33K ﹤0.01% 4429
2025
Q4
$369K Sell
189,431
-12,013
-6% -$19.7K ﹤0.01% 4566
2025
Q3
$170K Sell
201,444
-427,457
-68% -$314K ﹤0.01% 4713
2025
Q2
$456K Sell
628,901
-2,169,762
-78% -$1.63M ﹤0.01% 4467
2025
Q1
$2.41M Sell
2,798,663
-270,074
-9% -$401K ﹤0.01% 3932
2024
Q4
$5.16M Sell
3,068,737
-496,506
-14% -$1.19M ﹤0.01% 3719
2024
Q3
$10.2M Sell
3,565,243
-262,334
-7% -$679K ﹤0.01% 3399
2024
Q2
$8.96M Buy
3,827,577
+95,773
+3% +$250K ﹤0.01% 3439
2024
Q1
$11M Sell
3,731,804
-161,833
-4% -$459K ﹤0.01% 3307
2023
Q4
$11.6M Buy
3,893,637
+154,788
+4% +$443K ﹤0.01% 3321
2023
Q3
$11.8M Buy
3,738,849
+134,525
+4% +$438K ﹤0.01% 3238
2023
Q2
$13.9M Buy
3,604,324
+302,928
+9% +$873K ﹤0.01% 3252
2023
Q1
$9.14M Sell
3,301,396
-44,927
-1% -$94.2K ﹤0.01% 3356
2022
Q4
$6.02M Buy
3,346,323
+136,829
+4% +$264K ﹤0.01% 3642
2022
Q3
$6.8M Sell
3,209,494
-46,538
-1% -$117K ﹤0.01% 3619
2022
Q2
$8.76M Buy
3,256,032
+2,050,046
+170% +$7.63M ﹤0.01% 3570
2022
Q1
$5.23M Sell
1,205,986
-45,862
-4% -$188K ﹤0.01% 3931
2021
Q4
$6.49M Buy
1,251,848
+23,560
+2% +$126K ﹤0.01% 3883
2021
Q3
$7.54M Buy
1,228,288
+231,491
+23% +$1.84M ﹤0.01% 3799
2021
Q2
$10.1M Sell
996,797
-3,203
-0.3% -$34.7K ﹤0.01% 3637
2021
Q1
$13.8M Hold
1,000,000
﹤0.01% 3388
2020
Q4
$10.8M Hold
1,000,000
﹤0.01% 3315
2020
Q3
$10.8M Buy
+1,000,000
New +$10.7M ﹤0.01% 3181

Other funds holding NAUT

BlackRock's NAUT Position: Q2 2026 in Review

BlackRock increased its Nautilus Biotechnolgy (NAUT) stake by 1,332% in Q2 2026, buying an estimated $6.6M and bringing the position to 2,687,226 shares worth $5.03M. The position accounts for ﹤0.01% of the portfolio, ranked #3923.

BlackRock first reported a position in NAUT in Q3 2020 and has held it in 24 quarters since. The position peaked at $13.9M in Q2 2023. 93 funds tracked by Wall St. Rank hold NAUT as of Q2 2026.

  • BlackRock held 2,687,226 shares of Nautilus Biotechnolgy worth $5.03M as of Q2 2026.
  • BlackRock bought 2,499,555 Nautilus Biotechnolgy shares in Q2 2026, an estimated $6.6M.
  • Nautilus Biotechnolgy made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #3923 holding.
  • BlackRock first reported a position in Nautilus Biotechnolgy in Q3 2020 and has held it in 24 quarters since.
  • BlackRock's Nautilus Biotechnolgy position peaked at $13.9M in Q2 2023.
  • 93 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.